Clinical Trial Update: Carfilzomib + High Dose Melphalan as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating carfilzomib with high-dose melphalan as a preparative regimen for autologous stem cell transplant in multiple myeloma; study complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Carfilzomib (carfilzomib)
• melphalan (high-dose) (melphalan)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-07-10